DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▼ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0015695 | Fatty Liver | ALOX12 | 239 | arachidonate 12-lipoxygenase, 12S type | P18054 |
C0243026 | Sepsis | ALOX12 | 239 | arachidonate 12-lipoxygenase, 12S type | P18054 |
C0018801 | Heart failure | ALOX12 | 239 | arachidonate 12-lipoxygenase, 12S type | P18054 |
C1704272 | Benign Prostatic Hyperplasia | ALOX12 | 239 | arachidonate 12-lipoxygenase, 12S type | P18054 |
C0038436 | Post-Traumatic Stress Disorder | ALOX12 | 239 | arachidonate 12-lipoxygenase, 12S type | P18054 |
C0040560 | Toxoplasmosis, Congenital | ALOX12 | 239 | arachidonate 12-lipoxygenase, 12S type | P18054 |
C0524851 | Neurodegenerative Disorders | ALOX12 | 239 | arachidonate 12-lipoxygenase, 12S type | P18054 |
C0085580 | Essential Hypertension | ALOX12 | 239 | arachidonate 12-lipoxygenase, 12S type | P18054 |
C1691228 | Cystic Kidney Diseases | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0018798 | Congenital Heart Defects | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0282577 | Congenital Disorders of Glycosylation | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0016952 | Galactosemias | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0040517 | Gilles de la Tourette syndrome | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C2931006 | Congenital disorder of glycosylation type 1L | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0085413 | Polycystic Kidney, Autosomal Dominant | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0221356 | Brachycephaly | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0018816 | Heart Septal Defects | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0029422 | Osteochondrodysplasias | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0014877 | Esotropia | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0158683 | Polycystic liver disease | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0036341 | Schizophrenia | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0007222 | Cardiovascular Diseases | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0206754 | Neuroendocrine Tumors | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0033975 | Psychotic Disorders | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
C0000768 | Congenital Abnormality | ALG9 | 79796 | ALG9 alpha-1,2-mannosyltransferase | Q9H6U8 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024